A recent report published by BMJ highlights the persisting issue of counterfeit and substandard medicines in Nigeria, despite the country’s regulatory efforts to address the problem.
The National Agency for Food and Drug Administration and Control (NAFDAC) claims that a majority of medicines sold in Nigeria today are legitimate, compared to 20 years ago when an estimate of two thirds of medicines sold such as antimalarials and antibiotics, were substandard and falsified. However, while progress has been made, the report found that the battle against counterfeit and substandard medicines in Nigeria remains an ongoing challenge that requires continued attention and enforcement.
Read the article here.
